Mereo BioPharma Group plc - MREO Net earnings per one share for the last twelve months

Mereo BioPharma Group (MREO) - corporate logo

Mereo BioPharma (MREO) is actively investing in therapies for rare pathologies, including osteogenesis imperfecta, as it vies for leadership in the segment. The strategy is based on building a highly specialized portfolio of genetic and oncological drugs, while partnerships with global behemoths minimize costs for final testing. This chart's linear price action reflects an EPS of 36.50, while the company implements energy-saving systems and emission filtration in its laboratories.

MREO: Mereo BioPharma Group plc Net earnings per share for the last 12 months 02/11/2024 - 11/15/2026

Mereo BioPharma Group plc - analytical breakdowns and key metrics (MREO)

- stock quotes and analyst forecast:
Quote Chart mereobiopharma.com|MREO - Analyst Consensus Forecast
- issuer market value details:
Market Value Mereo BioPharma Group PLC|MREO - Enterprise Value
- company book value details:
Equity per Share Mereo BioPharma|MREO - Company Net Assets|Market Value to Book Value mereobiopharma.com|MREO - Aggregate Company Assets
- company total debt and liquidity indicators:
Aggregate Debt to Equity Mereo BioPharma|MREO - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital mereobiopharma.com|MREO - Company Aggregate Debts|Debts to Book Capitalization Mereo BioPharma Group plc|MREO - Company Long-Term Debt|Company Short-Term Loans and Borrowings Mereo BioPharma|Quick Liquidity Indicator mereobiopharma.com
- earnings and valuation multiples information:
MREO - Net Profit|Projected Future Earnings Mereo BioPharma|MREO - Price to Earnings Ratio|Projected Price to Earnings mereobiopharma.com|MREO - PEG Multiple|Company Value to EBITDA Mereo BioPharma Group plc|MREO - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Mereo BioPharma|MREO - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months mereobiopharma.com|MREO - Earnings per share growth in current year|Expected net earnings per share growth next year Mereo BioPharma
- sales volume and revenue information:
MREO - Company Sales|Company Future Revenue mereobiopharma.com|MREO - P/S Multiple|Price-to-Projected Revenue Ratio Mereo BioPharma Group PLC|MREO - Sales Growth YoY (TTM)
Fundamental company valuation:MREO - Mereo BioPharma Group PLC
Brand item of mereobiopharma.com

For the biotechnology sector, Mereo BioPharma (MREO) annual earnings per share dynamics serve as a key metric for capitalization efficiency. This indicator measures the percentage change in net income over a rolling 12-month period, neutralizing US dollar exchange rate fluctuations. By analyzing the annual EPS TTM YoY trend, an investor determines the growth rate of the business's real value. The influx of partner advances has stabilized liquidity, creating a foundation for the recovery of this metric.

Competitor analysis

Earnings per one share for the last 12 months VRTX|ALNY: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insmed Inc (INSM)|UTHR (United Therapeutics Corporation) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BMRN (BioMarin)|Net earnings per share for the last 12 months BBIO (BridgeBio)|BGM: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Cogent Biosciences, Inc. COGT|XERS (Xeris Biopharma Inc) - Earnings per one share for the last 12 months|Keros Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ARCT (Arcturus Therapeutics)|ETON: Net earnings per share (EPS TTM)|Kamada Ltd (KMDA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Fulcrum Tx|ABEO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PLX|Net earnings per share for the last 12 months Pliant Therapeutics, Inc. PLRX|Net earnings per share (EPS TTM) APLT (Applied Therapeutics Inc.)|Net earnings per share (EPS TTM) Rein Therapeutics Inc. RNTX|gelteq.com - Net earnings per share (EPS TTM)|AYTU - Net earnings per share (EPS TTM)|CMMB: Net earnings per share (EPS TTM)|SRx Health Solutions Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Polyrizon Ltd|AEZS (Aeterna Zentaris) - Earnings per share for the last four quarters|Earnings per share for the last twelve months CTD Holdings (CYTH)|INZY: Earnings per one share for the last 12 months|Earnings per share for the last twelve months Reneo Pharmaceuticals Inc. RPHM|Net earnings per share for the last four quarters COSCIENS Biopharma Inc. (CSCI)